drugset / Trial / NCT00483470
Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose
RandomizedParallel-groupOpen-labelPrevention
Summary
As per request by the Heath Authorities, the present clinical study will assess the immunogenicity and safety
Timeline
- Start
- 2007-06
- Primary completion
- 2008-05
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HAVRIX 720 | Vaccine | 0.5 ml | Intramuscular |
| Subject | Varicella vaccine | Vaccine | 0.5 ml | Intramuscular |